SMTL ID : 9knh.1

Structural complex of FTO bound with Dac590

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

monomer

Ligands

1 x 01: 2-[[2-chloranyl-4-(3,5-dimethyl-1,2-oxazol-4-yl)-6-fluoranyl-phenyl]amino]-5-methoxy-benzoic acid

01.1: 17 residues within 4Å: Chain A: L.63, L.64, T.65, P.66, R.69, Y.79, Y.81, L.82, A.200, V.201, S.202, H.204, H.205, D.206, E.207, R.295 Ligands: OGA.2 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.81, A:Y.81, A:L.82, A:L.82, A:H.204, A:E.207 Hydrogen bonds: A:S.202, A:E.207 Halogen bonds: A:T.65, A:S.202

1 x OGA: N-OXALYLGLYCINE(Non-covalent)

OGA.2: 12 residues within 4Å: Chain A: R.69, N.178, V.201, V.217, Y.268, V.282, R.289, S.291, T.293, R.295 Ligands: 01.1, FE.3 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:R.69, A:N.178, A:Y.268, A:S.291, A:S.291 Salt bridges: A:R.289, A:R.295

1 x FE: FE (III) ION(Non-covalent)

FE.3: 4 residues within 4Å: Chain A: H.204, D.206, H.280 Ligands: OGA.2 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.204, A:D.206, A:H.280

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yang, T. et al., Development of Orally Bioavailable FTO Inhibitors with Potent Antileukemia Efficacy. J.Med.Chem. (2025)

Release Date

2025-09-03

Peptides

Alpha-ketoglutarate-dependent dioxygenase FTO: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Alpha-ketoglutarate-dependent dioxygenase FTO

Related Entries With Identical Sequence